Brought to you by 
Vanda Pharmaceuticals nets $55.4mm from IPO
03 Nov 2014
Executive Summary
Vanda Pharmaceuticals, a start-up biotech developing small-molecule psychiatric drugs, netted $55.4mm from its IPO of 5.96mm shares (including the overallotment) at $10 apiece. In December 2005 the company filed for a $75mm IPO, and later in March for a $92.5mm one.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Vanda Pharmaceuticals nets $55.4mm from IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice